drugset / Trial / NCT00349739
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Summary
The purpose of this study is to evaluate whether anecortave acetate can slow or stop the progression of age-related macular degeneration in patients who do not qualify for other studies and have no other treatment options.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 15 mg | Other |
| Subject | Anecortave Acetate | Small molecule | 30 mg | Other |